Skip to content

uniQure QURE Net Income

Net Income at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$185M-22.5%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-$128.45M+3.4%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.81M-100%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$122.93M+9.6%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$55.93M+56.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$74.11M-33.9%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's net income?
uniQure (QURE) reported net income of -$53.54M in Q1 2026.
How has uniQure's net income changed year-over-year?
uniQure's net income decreased by 22.7% year-over-year, from -$43.64M to -$53.54M.
What is the long-term trend for uniQure's net income?
Over 3 years (2022 to 2025), uniQure's net income has grown at a 14.2% compound annual growth rate (CAGR), from -$133.6M to -$198.97M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.